Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors

Gamo, Nao J., Wang, Min, Arnsten, Amy F.T.·2010·Journal of the American Academy of Child & Adolescent Psychiatry

Cited by (232)

Items 201–232 of 232

  1. Comorbidity in ADHD: A Neuropsychological Perspective
    Julio César Flores Lázaro, Mara Alejandra Salgado Soruco · 2012 · InTech eBooks
  2. Possible Involvement of Glutamatergic, Adrenergic and Dopaminergic System in Methylphenidate - induced Motor Activity and Mood-related Alterations in Rats
    Kowsar Jahanbakshi, Sulail Fatima, Majid Motaghinejad, Manijeh Motevalian · 2021 · Journal of Advances in Medical and Biomedical Research
  3. Catecholamine influences on prefrontal cortex circuits and function
    Amy F.T. Arnsten, Craig W. Berridge · 2014 · Cambridge University Press eBooks
  4. Intervention, Treatment, and Management of ADHD
    Timo D. Vloet, Georg G. von Polier, Beate Herpertz‐Dahlmann · 2020
  5. Maternal Transfer of Dietary Methylmercury and Implications for Embryotoxicity in Fathead Minnows (Pimephales promelas)
    Kristin N. Bridges · 2016 · University of North Texas Digital Library (University of North Texas)
  6. Stimulant side effects: a pharmacogenetic/developmental perspective
    Florence Lévy · 2013
  7. Investigating the Efficacy of Transcranial Direct Current Stimulation in Managing ADHD and Co-occurring Conditions
    Syed Adnan Ali, Syed Noor Ali, Rehan Khan · 2023 · Preprints.org
  8. METHYLPHENIDATE AND ATOMOXETINE TREATMENT DURING ADOLESCENCE IN THE SPONTANEOUSLY HYPERTENSIVE RAT: MECHANISMS UNDERLYING HIGH COCAINE ABUSE LIABILITY IN ATTENTION DEFICIT/HYPERACTIVITY DISORDER
    Sucharita Sen Somkuwar · 2013 · UKnowledge (University of Kentucky)
  9. Therapy for ADHD Directed Towards Addressing the Dual Imbalances in Mental Effort and Reward as Illustrated in the Mental Effort-Reward Imbalances Model (MERIM)
    Alison Sally Poulton · 2015 · InTech eBooks
  10. PRECLINICAL EVALUATION OF LOBELINE FOR THE TREATMENT OF ADHD: COMPARISON WITH PSYCHOSTIMULANT THERAPIES
    Yolanda S. Williams · 2011 · UKnowledge (University of Kentucky)
  11. Stimulant Side Effects and the D1/D2 Receptor Gene Activity
    Florence Lévy · 2014 · The ADHD Report
  12. Neuropsychological Endophenotypes of Attention- Deficit/Hyperactivity Disorder Neuropsychologische Endophänotypen des Aufmerksamkeitsdefizit-/Hyperaktivitätssyndroms
    Julia M. Geissler · 2013
  13. PrefrontalandMonoaminergicContributionstoStop-Signal TaskPerformanceinRats
    N. A. Oganya · 2011
  14. Negligible Effects of Acute Atomoxetine Administration on Visual Working Memory in the Macaque Monkey
    Lindsey T. Thurston · 2016 · QSpace (Queen's University Library)
  15. Noradrenergic modulation of functional brain networks underlying executive control
    Andrew L. Breeden · 2016 · DigitalGeorgetown (Georgetown University Library)
  16. Choice in C57BL/6n Mice: Behavioral and Pharmacological Mechanisms of Concurrent Schedule Performance
    Craig Cummings · 2016
  17. Inducing a Functional-Pharmacological Coupling in the Human Brain to Achieve Improved Drug Effect
    Roy Sar-El, Gal Raz, Nitzan Lubianiker, Haggai Sharon, Talma Hendler · 2020 · Frontiers in Neuroscience
  18. Experimentally altered male mating behaviour affects offspring exploratory behaviour via nongenetic paternal effects
    Alex R. De Serrano, Mitchel J. Daniel, F. Helen Rodd · 2020 · Behavioural Brain Research
  19. The Influence of Pantogam and Atomoxetine on Attention Stability and Distribution of Dopamine D2 and GABAB Receptors in the Attention Deficit Mouse Model
    Georgy I. Kovalev, N. A. Sukhorukova, Екатерина Валерьевна Васильева, Е. А. Кондрахин, Рамиз Меджидович Салимов · 2022 · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry
  20. The D1 receptor agonist SKF38393 improves waiting impulsivity in a baseline dependent manner
    Sara Abdulkader, John Gigg · 2026 · Medical Research Archives
  21. Neurobiology of Attention Deficit Hyperactivity Disorder
    Stephen V. Faraone, Nevena V. Radonjić · 2024 · Springer eBooks
  22. Does Dexamphetamine Cause Addiction? A Narrative Review
    Hazer Khalifa, Emily Hibbert, Natalie Gauci, Alison Sally Poulton · 2025 · Psychoactives
  23. Transcranial random noise stimulation shifts time reproduction in opposite directions for ADHD and TD individuals
    Fatima Asad, Keri Anne Gladhill, Matthew Peterson, Martin Wiener · 2025 · Neuropsychologia
  24. Pharmacological Reversal of Attention Deficits in Non-Human Primates: Implications for Alzheimer’s Disease
    Casey R. Vanderlip, Shelby R. Dunn, Joseph S. Cefalu, Theresa M. Ballard, Joseph G. Wettstein, Courtney Glavis‐Bloom · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Attention-Deficit/Hyperactivity Disorder Medication Use: Stimulant Medication and Non-stimulant Medication
    Yarto Lai · 2025 · Theoretical and Natural Science
  26. Co-administration of modafinil, atomoxetine, and citalopram increases exploratory behavior, produces withdrawal signs, and enhances self-administration of this drug mixture
    Jorge Juárez, Amanda C. Hernandez De la Torre, Jesús E. Yepez · 2025 · Pharmacological Research - Reports
  27. Modulation noradrénergique de l’attention
    Carole Guedj · 2016 · theses.fr (ABES)
  28. Implication of the locus coeruleus in effort processing : electrophysiological studies
    Pauline Bornert · 2021 · theses.fr (ABES)
  29. Cortical mechanisms of comorbidity between pain sensitization and attention-deficit/hyperactivity disorder (ADHD) in a mouse model
    Sarah Bou Sader Nehme · 2024 · theses.fr (ABES)
  30. Concomitant activation of D1 dopamine and α2A adrenergic receptors improves cognition better than methylphenidate in two rodent behavioral tests
    Luke Bransom, Ava P. Bassett, Mi Zhou, Richard B. Mailman, Y. Yang · 2026 · Discover Pharmaceutical Sciences
  31. Detrimental effects of atomoxetine on visual signal detection in rats: comparison with ADHD psychomotor stimulant drugs
    Livia J.F. Wilod Versprille, Koji Yano, A. Petersen, Jeffrey W. Dalley, Trevor William Robbins · 2026 · Psychopharmacology
  32. Cognitive impairment: quantification and possibilities for pharmacological treatment
    Charlotte R. Housden · 2013 · Apollo (University of Cambridge)